(Q40105810)

17 September 2017

1 reference

title

Suppressor mechanisms in tumor immunity (English)

1 reference

17 September 2017

1

1 reference

17 September 2017

I Hellström

2

1 reference

17 September 2017

K E Hellström

series ordinal

3

1 reference

17 September 2017

publication date

1 March 1983

1 reference

17 September 2017

1 reference

17 September 2017

volume

39

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

235-242

1 reference

Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen

17 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01955286

Helper and suppressor T cell factors

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01955286

Immunity to murine sarcoma virus induced tumours. IV. Direct cellular cytolysis of 51Cr labelled target cells in vitro and analysis of blocking factors which modulate cytotoxicity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01955286

Specific anti-tumor responses of cultured immune spleen cells III. Further characterization of cells which synthesize factors with blocking and antiserum-dependent cellular cytotoxic (ADC) activities

21 January 2018

1 reference

12 December 2020

Tolerance and contact sensitivity to DNFB in mice. VI. Inhibition of afferent sensitivity by suppressor T cells in adoptive tolerance

1 reference

12 December 2020

Evidence that tumor antigens enhance tumor growth in vivo by interacting with a radiosensitive (suppressor?) cell population

1 reference

12 December 2020

T cell subset interactions in the regulation of syngeneic tumor immunity

1 reference

12 December 2020

In vivo effects of antibodies to immune response gene products. I. Haplotype-specific suppression of humoral immune responses with a monoclonal anti-I-A.

1 reference

12 December 2020

Correlation between immune complexes and prognostic factors in Hodgkin's disease

1 reference

12 December 2020

Proceedings: Proposed mechanisms by which autochthonous neoplasms escape immune rejection

1 reference

12 December 2020

Towards a network theory of the immune system.

1 reference

12 December 2020

T Cell Control of Antibody Production

1 reference

12 December 2020

Hapten-coupled monoclonal anti-I-A antibodies provide a first signal for the induction of suppression

1 reference

12 December 2020

Activation of suppressor T cells by tumour cells and specific antibody

1 reference

12 December 2020

Cellular consequences in the suppression of antibody response by the antigen-specific T-cell factor

1 reference

12 December 2020

The Role of Antigen-Specific T Cell Factors in the Immune Response

1 reference

12 December 2020

The nature of immune complexes in human cancer sera

1 reference

12 December 2020

The genetic and cellular basis of antigen and receptor stimulated regulation

1 reference

12 December 2020

Suppressor Cells: Permitters and Promoters of Malignancy?

1 reference

12 December 2020

Regulation of immune response to tumor antigen: interference with syngeneic tumor immunity by anti-IA alloantisera

1 reference

12 December 2020

Specific anti-tumor responses by cultured immune spleen cells. I.In vitro culture method and initial characterization of factors which block immune cell-mediated cytotoxicityin vitro

1 reference

12 December 2020

Regulation of the immune response to tumor antigen. VI. Differential specificities of suppressor T cells or their products and effector T cells

1 reference

12 December 2020

Purification and partial characterization of a tumor-specific blocking factor from sera of mice with growing chemically induced sarcomas

1 reference

12 December 2020

T–T cell collaboration in rejection of a syngeneic SV40-induced sarcoma in mice

1 reference

12 December 2020

Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population

1 reference

12 December 2020

Suppressor T Lymphocytes Control the Development of Primary Skin Cancers in Ultraviolet-Irradiated Mice

1 reference

12 December 2020

Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice

1 reference

12 December 2020

Regulation of the immune response to tumor antigen. VIII. The effects of host specific anti-I-J antibodies on the immune response to tumors of different origin.

1 reference

12 December 2020

T-T hybridoma product specifically suppresses tumor immunity

1 reference

12 December 2020

Effects of blocking helper T cell induction in vivo with anti-Ia antibodies. Possible role of I-A/E hybrid molecules as restriction elements

1 reference

12 December 2020

Regulation of cell-mediated immunologic reactivity to Moloney murine sarcoma virus-induced tumors. II. Nature of blocking and unblocking factors in serum

1 reference

12 December 2020

Antigen-specific purification of blocking factors from sera of mice with chemically induced tumors

1 reference

12 December 2020

Reduced tumor growth after low-dose irradiation or immunization against blastic suppressor T cells

1 reference

12 December 2020

Antigen-antibody complexes generate Lyt 1 inducers of suppressor cells.

1 reference

12 December 2020

Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease

1 reference

12 December 2020

Immune Complexes in Cancer: Demonstration of Complexes in Mice Bearing Neuroblastomas2

1 reference

12 December 2020

Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum

1 reference

12 December 2020

Sequential quantitation of circulating immune complexes in syngeneic and allogeneic rats bearing Moloney sarcomas

1 reference

12 December 2020

Cell-mediated suppression of tumor immunity has a non-specific component. I. Evidence from transplantation tests

1 reference

12 December 2020

Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen

1 reference

12 December 2020

Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes

1 reference

12 December 2020

Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts

1 reference

12 December 2020

Suppression of cytotoxic lymphocyte responses in vitro by soluble products of alloantigen-activated spleen cells

1 reference

12 December 2020

Antigen- and receptor-driven regulatory mechanisms. IV. Idiotype-bearing I-J+ suppressor T cell factors induce second-order suppressor T cells which express anti-idiotypic receptors

1 reference

12 December 2020

Properties of Primed Suppressor T Cells and their Products

1 reference

12 December 2020

Immunological enhancement of tumor homografts in mice: a review.

1 reference

12 December 2020

Does Perfusion with Treated Plasma Cure Cancer?

1 reference

12 December 2020

Proceedings: Implications of the fetal antigen theory for fetal transplantation

1 reference

12 December 2020

Specific blocking factors--are they important?

1 reference

12 December 2020

Suppressor pathways in tumor immunity: a requirement for Qa-1 positive tumor-bearer spleen T cells in suppression of the afferent immune response to tumor antigens.

1 reference

12 December 2020

Antigen-specific T-cell-mediated suppression. I. Induction of L-glutamic acid60-L-alanine30-L-tyrosine10 specific suppressor T cells in vitro requires both antigen-specific T-cell-suppressor factor and antigen

1 reference

12 December 2020

In vitro synthesis of tumor-specific factors with blocking and antibody-dependent cellular cytotoxicity (ADC) activities

1 reference

12 December 2020

Suppression of tumor rejection by autologous anti-idiotypic immunity

1 reference

12 December 2020

Immunologic mechanisms in UV radiation carcinogenesis

1 reference

12 December 2020

Suppressor T cells in cell-mediated immunity

1 reference

12 December 2020

Immunological facilitation, a broadening of the concept of the enhancement phenomenon.

1 reference

12 December 2020

Circulating immune complexes in sera of patients with Burkett's lymphoma and nasopharyngeal carcinoma

1 reference

12 December 2020

In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice

1 reference

12 December 2020

Treatment of feline leukemia and reversal of FeLV byex vivo removal of IgG: A preliminary report

1 reference

12 December 2020

Human blood T lymphocytes that suppress the mixed leukocyte culture reactivity of lymphocytes from HLA-B14 bearing individuals

1 reference

12 December 2020

Immunological circuits: cellular composition

1 reference

12 December 2020

Cellular interaction between cytotoxic and suppressor T cells against syngeneic tumors in the mouse

1 reference

12 December 2020

Foetal "antigens" in cancer.

1 reference

12 December 2020

Tumor-enhancing suppressor activator T cells in spleens and thymuses of tumor immune mice

1 reference

12 December 2020

The genetic and cellular basis of regulation of the immune response to tumor antigens

1 reference

12 December 2020

Hypothesis. The physiological regulation of immunity: differential regulatory contributions of peripheral and central lymphon compartments

1 reference

12 December 2020

Regression of polyoma tumor metastasis by combined unblocking and bcg treatment-correlation with induced alterations in tumor immunity status

1 reference

12 December 2020

Genetic control of the immune response to myoglobins. IV. Inhibition of determinant-specific Ir gene-controlled antigen presentation and induction of suppression by pretreatment of presenting cells with anti-Ia antibodies

1 reference

12 December 2020

Extensive necrosis of spontaneous canine mammary adenocarcinoma after extracorporeal perfusion over Staphylococcus aureus Cowans I. I. Description of acute tumoricidal response: morphologic, histologic, immunohistochemical, immunologic, and serologi

1 reference

12 December 2020

Suggestive Evidence That the “Blocking Antibodies” of Tumor-Bearing Individuals May Be Antigen-Antibody Complexes

1 reference

12 December 2020

Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens

1 reference

12 December 2020

Antigen-specific suppressor T cell interactions. I. Induction of an MHC-restricted suppressor factor specific for L-glutamic acid50-L-tyrosine50

1 reference

12 December 2020

Effect on Tumour Growth in Syngeneic Recipients of Antibodies Against Tumour-Specific Antigens in Methylcholanthrene-Induced Mouse Sarcomas

1 reference

12 December 2020

Immunological enhancement of tumor growth by syngeneic thymus-derived lymphocytes

1 reference

12 December 2020

Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen

1 reference

12 December 2020

Loss of Ia-bearing splenic adherent cells after whole body ultraviolet irradiation

1 reference

12 December 2020

Production of T-cell lines with inhibitory or stimulatory activity against syngeneic tumors in vivo. A preliminary report

1 reference

12 December 2020

Regulation of the immune response to tumor antigen

1 reference

12 December 2020

Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts

1 reference

12 December 2020

Ex vivo removal of serum igg in a patient with colon carcinoma.Some biochemical, immunological and histological observations

1 reference

12 December 2020

Discussion paper: specific paralysis of the antitumor cellular immune response produced by growing tumors studied with a radioisotope footpad assay

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01955286

1 reference

17 September 2017

1 reference